No muscle atrophy without GSK-3β. Focus on "Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy"

被引：2
|
作者：
Dupont-Versteegden, Esther E. [1 ]
Waters, Christine [1 ]
机构：
[1] Univ Kentucky, Div Phys Therapy, Dept Rehabil Sci, Coll Hlth Sci, Lexington, KY 40536 USA
来源：
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY | 2011年 / 301卷 / 05期
关键词：
GROWTH-FACTOR-I; BETA-CATENIN; UBIQUITIN LIGASES; PATHWAY; INSULIN; RATS; HYPERTROPHY; INHIBITORS; EXPRESSION;
D O I：
10.1152/ajpcell.00310.2011
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：C980 / C981
页数：2
相关论文
共 50 条
  • [1] Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy
    Verhees, Koen J. P.
    Schols, Annemie M. W. J.
    Kelders, Marco C. J. M.
    den Kamp, Celine M. H. Op
    van der Velden, Jos L. J.
    Langen, Ramon C. J.
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2011, 301 (05): : C995 - C1007
  • [2] Inactivation of glycogen synthase kinase-3β (GSK-3β) enhances skeletal muscle oxidative metabolism
    Theeuwes, W. F.
    Gosker, H. R.
    Langen, R. C. J.
    Verhees, K. J. P.
    Pansters, N. A. M.
    Schols, A. M. W. J.
    Remels, A. H. V.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2017, 1863 (12): : 3075 - 3086
  • [3] Glycogen Synthase Kinase 3 (gsk-3) Inhibition Prevents Skeletal Muscle Atrophy In A Guinea Pig Model Of COPD
    Langen, R.
    Verhees, K.
    Baarsma, H.
    Pansters, N.
    Remels, A.
    Schols, A. M. W. J.
    Gosens, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [4] Inactivation of glycogen synthase kinase 3β (GSK-3β) enhances skeletal muscle oxidative metabolism
    Remels, Alexander
    Verhees, Koen
    Gosker, Harry
    Schols, Annemie
    Langen, Ramon
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [5] Glycogen synthase kinase-3 (GSK-3): A kinase with exceptional therapeutic potential
    Benbow, JW
    Helal, CJ
    Kung, DW
    Wager, TT
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 40, 2005, 40 : 135 - 147
  • [6] Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and Imaging
    Pandey, Mukesh K.
    DeGrado, Timothy R.
    THERANOSTICS, 2016, 6 (04): : 571 - 593
  • [7] In vivo administration of insulin from portal vein activates Akt and glycogen synthase, inhibits glycogen synthase kinase-3 (GSK-3) activity in the mouse skeletal muscle
    Miki, T
    Sakaue, M
    Kasuga, M
    DIABETES, 1999, 48 : A283 - A283
  • [8] Expression and localization of glycogen synthase kinase-3 (GSK-3) in mouse
    Yao, HB
    Shaw, PC
    Wan, DCC
    FASEB JOURNAL, 2001, 15 (04): : A547 - A547
  • [9] Glycogen synthase kinase-3 (GSK-3) inhibitors reach the clinic
    Medina, Miguel
    Castro, Ana
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2008, 11 (04) : 533 - 543
  • [10] Regulation of glycogen synthase kinase 3 (GSK-3) and glycogen synthase (GS) by insulin and amino acids (AA) in human skeletal muscle
    Liu, ZQ
    Nicklas, E
    Wu, YS
    Jahn, L
    Price, W
    Barrett, E
    DIABETES, 2003, 52 : A345 - A345
12345